Metabolic

RT Max 110mg

Name: RT Max 110mg
Brand: Peak Protocol
SKU: rt-max-110
Price: 2950 ZAR
Availability: InStock

Maximum-strength dual-compound cartridge.

Retatrutide 50mg + Tirzepatide 60mg (110mg total) — high-dose combination cartridge.

R2950

per vial

Ask a specialist

3rd-party verified
Cold-chain shipping
Discreet packaging
99.8% purity

What it is

RT Max 110mg is a high-dose combination cartridge pairing Retatrutide (50mg) with Tirzepatide (60mg) for extended-cycle metabolic protocols.

Key benefits

Most aggressive appetite and craving suppression
Powerful glycemic and lipid improvements
Maximum fat-loss potential per cartridge
Extended dosing window per vial

How it works

Triple-receptor (GLP-1 / GIP / Glucagon) activation from Retatrutide layered with Tirzepatide's dual agonism delivers compounded satiety, insulin sensitivity, and basal energy expenditure.

Who it's best for

Advanced metabolic protocols
Long-cycle recomposition programs
Medically supervised users plateaued on single-compound therapy

Suggested protocol

Titrate weekly under medical supervision. Start conservatively and escalate based on tolerance.

Administration guide

Weekly subcutaneous injection via the pen. Rotate injection sites.

Storage instructions

Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Frequently asked questions

How quickly will I notice results from RT Max 110mg?

Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.

Can I stack this with other Peak Protocol products?

Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.

Is this third-party tested?

Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.

What is the return policy?

Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.

Important disclaimer. All Peak Protocol compounds are intended strictly for laboratory research and educational purposes. They are not approved by the FDA for human consumption, treatment, or therapeutic use. Statements have not been evaluated by the FDA. Consult a qualified medical professional before initiating any protocol.